Menu
1st, 2nd prizes of National Science & Technology Progress Award Won by PUMCH
CopyFrom: PUMCH UpdateTime: 2015-06-18 Hits: 261 Font Size: SmallBig
Year
Name
Prize
Department
Project name
Main researchers
1985
National S&T Progress Award
1
Obstetrics and Gynecology
Fundamental solution to chorioepithelioma and promotion of the method Song Hongzhao, Wu Baozhen, Tang Minyi, Wang Yuan'e, Yang Xiuyu (Chen Jiageng Medical Award 1989)
1989
National S&T Progress Award
2
Surgery
Progress in Parenteral Nutrition Jiang Zhuming, Zhu Yu, Wu Weiran, He Guizhen, Yang Naifa
1989
National S&T Progress Award
2
Obstetrics and Gynecology
Research on lymphatic metastasis of oophoroma Wu Baozhen, Lang Jinghe, Huang Rongli, Tang Minyi, Zhao Rongguo, Lian Lijuan
1992
National S&T Progress Award
1
Endocrinology, Neurosurgery, Ophthalmology, Otorhinolaryngology, Pathology, Radiology, Radiotherapy,
Clinical and basic research on pituitary tumors (hormone secretion type) Shi Yifan, Ren Zuyuan, Deng Jieying, Lao Yuanxiu, Lu Zhaolin, Yin Zhaoyan, Wang Zhizhong, Zeng Xu, Jin Zimeng, Zhou Juechu, Wang Weijun, Zhang Tao, Zhao Jun, Li Baoluo, Su Changbao
1993
National S&T Progress Award
2
Internal medicine (Gastroenterology)
Clinical and basic research on pituitary tumors (hormone secretion type) Chen Yuanfang, Pan Guozong, Chen Shoupo, Lu Guojun, Zhou Zhichao, Hou Xue, Sun Gang
1995
National S&T Progress Award
2
Internal medicine
Clinical research on treating tachyarrhythmia with RF generator Wu Ning, Lan Zhiqiang
1995
National S&T Progress Award
2
pathology
Molecular biological characteristics of human pancreatic carcinoma and reversion of its malignant phenotype through antisense gene regulation Liu Tonghua, Chen Jie, Wang Zhiyong, Cui Quancai, Li Hewei, Li Dechun, Zeng Chunxun, Yao Chongzheng, Guo Hongtao
1998
National S&T Progress Award
2
Endocrinology,PUHSC
Basic and clinical research on endothelin Zeng Zhengpei, Tang Chaoshu, Zhu Wenling, Zhou Airu, Zeng Weibiao, Niu Dadi, Jin Zhengyu, Tang Jian, Sun Meili
1999
National S&T Progress Award
2
Internal medicine
Modern Internal Medicine  Fang Qi, Zhu Yuanjue, Shi Yifan, Wu Ning, Guo Yupu, Mou Shanchu, Yao Lei
2002
National S&T Progress Award
2
ICU
Clinical and basic research on systemic infection and MODS  Chen Dechang, Liu Dawei, Ma Sui, Du Bin, Pan Jiaqi, Qiu Haibo, Sun Dongxu, Ma Penglin, Zhang Haitao, Zhu Li
2002
National S&T Progress Award
2
Endocrinology, Obstetrics and Gynecology, Radiology
Clinical and experimental research on primary osteoporosis Meng Xunwu, Xu Ling, Lin Shouqing, Zhou Xueying, Yu Wei, Xing Xiaoping, Qin Mingwei, Xia Weibo, Tian Junping
2002
National S&T Progress Award
2
Basic Surgery
Intestinal Mucosal Barrier Dysfunction and hGH Interference with Glutamine Jiang Zhuming, Wang Xiurong, He Guizhen, Liu Yuewu, Zhang Siyuan, Yu Jianchun, Ma Enling, Yang Naifa, Shu Hong
2005
National S&T Progress Award
2
Orthopedics
Series research on and clinical application of solutions to idiopathic scoliosis Qiu Guixing, Weng Xisheng, Zhang Jianguo, Wang Yipeng, Shen Jianxiong, Ye Qibin, Li Shugang, Wu Zhihong, Lin Jin, Tian Ye
2006
National S&T Progress Award
2
Obstetrics and Gynecology
Basic and clinical research on endometriosis Lang Jinghe, Li Yali, Piao Yunshang, Shen Keng, Wang Yanling, Liu Zhufeng, Sun Dawei, Leng Jinhua, Zhu Lan, Tan Xianjie
2008
National S&T Progress Award
2
Neurology
Research on epidemiology, interference and control of Parkinson's, dementia and their subtypes Zhang Zhenxin, He Wei, Zhang Junwu, Hong Zhen, Qu Qiumin, Tang Mouni, Li Hui, Wei Jing, Ji Chengjun, Zhang Xiaojun 
2008
National S&T Progress Award
2
Basic Surgery
Basic research on and clinical application of comprehensive solution to pancreatic cancer Zhao Yupei, Liao Quan, Zhang Taiping, Chen Ge, Guo Junchao, Dai Menghua, Liu Ziwen, Hu Ya, Cai Lixing, Zhu Yu 

Fundamental solution to chorioepithelioma and promotion of the method (1st prize, 1985)
From the 1950s, Song Hongzhao and his fellow researchers achieved a series of innovative results on chorioepithelioma: they were the first to use high dose chemotherapy, which turned a death rate of 90% to a cure rate of 90%. From 1959, primary tumor hysterectomy was abandoned and only drug treatment was applied so that patients may give birth to healthy babies. The metastasis mechanism of chorioepithelioma was also explained, and a method of clinical staging was proposed, which was later adopted by WHO. A survey was also carried out on the acephalocystis racemosa rates and risk factors among Chinese groups. This achievement turned chorioepithelioma into one of the earliest cancers that were completely cured, thus of significant scientific and social value. This achievement also won the National Science Conference Award in 1978 and first prize of scientific research results of the Ministry of Health in 1982.
(Caption) 1. 3-4-4-1 Song Hongzhao (L1) leads his team to make the rounds of the wards.

Completely cured patients may give birth to healthy babies. 
Progress in Parenteral Nutrition
Intestinal Mucosal Barrier Dysfunction and hGH Interference with Glutamine
(2nd prize, 1989 and 2002)
 
The "research team of parenteral and enteral nutrition in basic surgery department" led by Jiang Zhuming made a report on the treatment of critically ill patients using intravenous nutrition at the 1978 national conference, being the first clinical report of its kind in China. In 1979 a theses on improving the outcome of crucially ill patients through intravenous nutrition and elemental diet was published on Chinese Journal of Surgery, being the first Chinese these on parenteral and enteral nutrition that entered PubMed. In 1989, a world-first report on postoperative parenteral nutrition with hGH was quoted 184 times by SCI journals including New Eng J Med. The year 1991 a nation-leading series research on double measurement of intestinal permeability and bacterial translocation after glutamine dipeptide weakening. Based on PUMCH, the multi-disciplinary Chinese Society for Parenteral and Enteral Nutrition was established in 2004. The Society is responsible for researches on "nutrition support, outcome and cost/effect" and the promotion of clinical application.
(Caption) Song Qiang, a policeman who recovered from several penetrating wounds of the abdomen after receiving 9 operations and 370-day nutrition support at PUMCH in 1984-1985, has a photo taken with the medical team 25 years ago. 

Research on lymphatic metastasis of oophoroma (2nd prize, 1989)
Wu Baozhen and his team, through performing retroperitoneal lymph node dissection (RPLND) and lymphography, probed into the laws of lymphatic metastasis of oophoroma. Findings are that lymphatic metastasis is an important way of oophoroma spread (total rate 54.3%), and it is of equal chance that the tumor spreads to lymph of pelvic cavity or of aortaventralis. The team's application of lymphography was proved world-leading.
(Caption) Wu Baozhen (L2) and his team have a photo taken after winning the prize.

Clinical and basic research on pituitary tumors (hormone secretion type) (1st prize, 1992)
A research team, led by Shi Yifan and consisting staff from 9 departments (endocrinology, neurosurgery, ophthalmology, otorhinolaryngology, pathology, radiology, radiotherapy, anesthesiology and computer) performed clinical analysis on the largest sample group of pituitary tumor patients at home and abroad (1041 cases), and summed up the characteristics of various pituitary tumor cases in China. The team was the world first to propose the concept of two results, complete and partial damage, after pituitary apoplexy and corresponding treatment principles. By both introduction and independent innovation, the team led China into the world rank in pituitary tumor's diagnosis and operation, radiotherapy, drug treatment and pathology. In treating GH tumor with SMS, the team innovatively predicted and proved its affect on the function of the biliary system. It was preliminarily proved that pituitary tumor is a autonomous functioning tumor partly responding to hypothalamic hormones; and the research on blood supply of optic chiasma for the first time explained the mechanism by which pituitary micro-adenoma caused visual field defect. This research result highlighted PUMCH's advantage in cooperation between various departments.
(Caption) Shi Yifan (standing) discusses a case with some members of her research team.

Basic and clinical research on gastrointestinal hormones and their receptors (2nd prize, 1993)
Chen Yuanfang, Pan Guozong, Chen Shoupo and their fellow researchers were the first in China to establish radioimmunoassay for 8 gastrointestinal hormones, radioreceptor assay for 3 gastrointestinal hormones, preparation method for isolated pancreas and gastric cells, and bioassay of CCK, which laid a solid foundation for the research of gastrointestinal hormones.
(Caption) Chen Yuanfang discusses with fellow researchers questions on gastrointestinal hormones and gastrointestinal movements. 

Clinical research on treating tachyarrhythmia with RF generator (2nd prize, 1995)
Wu Ning and her fellow researchers, closely following world-advanced methods, used RF generator to treat PSVT, IVT and atrial flutter and achieved a world-leading success rate. They developed homemade RF generators, thus promoting the treatment of tachyarrhythmia with RF generators in China.
(Caption) 3-4-4-7 Wu Ning (L1) and other researchers treat patients.

  
Molecular biological characteristics of human pancreatic carcinoma and reversion of its malignant phenotype through antisense gene regulation (2nd prize, 1995)
The research team lead by Liu Tonghua was the first in China to establish 5 cell lines of human pancreatic carcinoma and 7 lines of implanted tumor in nude mice; it carried out tests of genic mutation and raised the diagnosis rate of pancreatic carcinoma; it carried out targeted molecular diagnosis and provided basis for treatment according to individuals. The team remained world-class in molecular biological research of human pancreatic carcinoma and its experimental gene therapy and contributed significantly to the diagnosis and treatment of pancreatic carcinoma.
(Caption) 3-4-3-6 Liu Tonghua (standing) and her team discuss cases.

 
Basic and clinical research on endothelin (2nd prize, 1998)
A research team led by Zeng Zhengpei and working in cooperation with the PUHSC and the Department of Cardiology was the first to make antiserum of endothelin and established several measuring methods. It was the world first to state that endothelin is a kind of endogenous damage factor produced by the body, and proved that endothelin played an important role in causing primary aldosteronism and pheochromocytoma.
(Caption) 3-4-4-8 Zeng Zhengpei (L3, front) has a photo taken with the research team.
   
Modern Internal Medicine (2nd prize, 1999)
Modern Internal Medicine, compiled by a team led by Fang Qi and consisting staff from the departments of international medicine, endocrinology and neurology, was published in August 1995. It introduces latest and mature findings at home and abroad, laid foundation for clinical progress and basic research, and is an important reference combining basic theories and clinical practice.
(Caption) Chief Editor Fang Qi (R2) has a photo taken with some of the authors.

Clinical and basic research on systemic infection and MODS (2nd prize, 2002)
Chen Dechang, Liu Dawei and their fellow researchers treated patients of systemic infection and MODS with hemodynamic monitoring and cardiovascular, respiratory and renal function support, which significantly improved the quality of diagnosis and treatment. Research was carried out into the relationship between the genetic polymorphism of IL-1 family cells and serious infection, and a homozygote was found that might be a high-risk genetic marker.
(Caption) Chen Dechang (R2) and Liu Dawei (R3) and other researchers discuss cases.
 
Clinical and experimental research on primary osteoporosis (2nd prize, 2002)
A team led by Meng Xunwu and consisting staff from departments of endocrinology, obstetrics and gynecology, and radiology carried out a survey of hip fracture and spinal fracture in elder women in Beijing, established 5 methods of measuring bone density and conducted related research. It was the first in China to propose a therapy of postmenopausal low-dose supplement of both estrogen and progestin, and carried out basic and clinical research on related drugs.
(Caption) Meng Xunwu (R3, front) has a photo taken with the research team.
 
Completely cured patients may give birth to healthy babies. 
Progress in Parenteral Nutrition
Intestinal Mucosal Barrier Dysfunction and hGH Interference with Glutamine
(2nd prize, 1989 and 2002)

 
The "research team of parenteral and enteral nutrition in basic surgery department" led by Jiang Zhuming made a report on the treatment of critically ill patients using intravenous nutrition at the 1978 national conference, being the first clinical report of its kind in China. In 1979 a theses on improving the outcome of crucially ill patients through intravenous nutrition and elemental diet was published on Chinese Journal of Surgery, being the first Chinese these on parenteral and enteral nutrition that entered PubMed. In 1989, a world-first report on postoperative parenteral nutrition with hGH was quoted 184 times by SCI journals including New Eng J Med. The year 1991 a nation-leading series research on double measurement of intestinal permeability and bacterial translocation after glutamine dipeptide weakening. Based on PUMCH, the multi-disciplinary Chinese Society for Parenteral and Enteral Nutrition was established in 2004. The Society is responsible for researches on "nutrition support, outcome and cost/effect" and the promotion of clinical application.
(Caption) Song Qiang, a policeman who recovered from several penetrating wounds of the abdomen after receiving 9 operations and 370-day nutrition support at PUMCH in 1984-1985, has a photo taken with the medical team 25 years ago. 

Series research on and clinical application of solutions to idiopathic scoliosis (IS) (2nd prize, 2005)
A team led by Qiu Guixing was the first in China to perform 3D orthomorphia on IS, and independently developed a pedicle screw system; it created IS animal models and probed into the molecular mechanism of IS; it established the world's largest IS databank and created PUMC classification, which received wide attention from home and abroad.
(Caption) Qiu Guixing (L2) leads young surgeons to have patient rounds.

Basic and clinical research on endometriosis (2nd prize, 2006)
A team led by Lang Jinghe, through basic and clinical research, proposed the theory of "endometrial determinism" and a therapy strategy of "addressing the root"; it established standards for the diagnosis and treatment of different types of endometriosis, promoted them across the country, thus significantly boosting the treatment quality of this disease.
(Caption) 3-4-13 Lang Jinghe and other surgeons perform an operation. 

Research on epidemiology, interference and control of Parkinson's, dementia and their subtypes (2nd prize, 2008)
Prof. Zhang Zhenxin, leading a team consisting staff from ten hospitals and institutions in China, spend 13 years investigating Parkinson's and dementia and created a new investigation method of home ward. The team was the first to publish the real rates of PD/AD in China and corrected the wrong conclusion of low PD/AD rates in this country. The research was highly praised by the international community.
(Caption) Zhang Zhenxin pays a home visit to a patient.

A team led by Zhao Yupei proposed a new theory on the origin and occurrence of pancreatic cancer cells, discovered new markers of human pancreatic cancer, screened out differentially expressed genes in MDR, and established a mapping of general alteration of gene expressions; it proposed the concept of high-risk groups of pancreatic cancer, established a green channel for diagnosis and treatment and an assessment system of preoperative resection, and took the lead in formulating treatment process as well as state and trade standards. PUMCH thus became a pancreatic cancer treatment center widely recognized at home and abroad.
(Caption) Zhao Yupei (L4) has a photo taken with the pancreas team.